Cargando…
A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast
Ductal carcinoma in situ (DCIS) of the breast is a nonobligate precursor of invasive breast cancer, accounting for 20 % of screen‐detected breast cancers. Little is known about the natural progression of DCIS because most patients undergo surgery upon diagnosis. Many DCIS patients are likely being o...
Autores principales: | Van Bockstal, Mieke R., Agahozo, Marie C., Koppert, Linetta B., van Deurzen, Carolien H.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004157/ https://www.ncbi.nlm.nih.gov/pubmed/31018242 http://dx.doi.org/10.1002/ijc.32362 |
Ejemplares similares
-
Radioactive Seed Versus Wire-Guided Localization for Ductal Carcinoma in Situ of the Breast: Comparable Resection Margins
por: Agahozo, Marie Colombe, et al.
Publicado: (2020) -
Stromal Changes are Associated with High P4HA2 Expression in Ductal Carcinoma in Situ of the Breast
por: Agahozo, Marie Colombe, et al.
Publicado: (2022) -
Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study
por: Doebar, Shusma C., et al.
Publicado: (2016) -
APOBEC3B Gene Expression in Ductal Carcinoma In Situ and Synchronous Invasive Breast Cancer
por: Sieuwerts, Anieta M., et al.
Publicado: (2019) -
Transcriptomic Properties of HER2+ Ductal Carcinoma In Situ of the Breast Associate with Absence of Immune Cells
por: Agahozo, Marie Colombe, et al.
Publicado: (2021)